Celebrex: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

26 March 2024

23 March 2024

  • curprev 13:3713:37, 23 March 2024Lazy talk contribs 1,722 bytes +1,722 Created page with "{{TreatmentInfo |drug_name=Celebrex (Celecoxib) and Other NSAIDs |FDA_approval=Yes (Celebrex is FDA-approved for arthritis and pain, but not specifically for cancer treatment) |used_for=Investigational use in cancer treatment due to anti-inflammatory, anti-angiogenic, and potential tumor growth inhibition properties |clinical_trial_phase=Early clinical trials and observational studies, including phase 2 trials combining Celebrex with conventional cancer treatments |commo..."